In this study, we showed that CASC2 was downregulated in the pancreatic cancer cell lines CAPAN-1, BxPC-3, JF305, and PANC-1 compared with levels in normal pancreatic HPDE6-C7 cells. Here, CASC2 is linked to pancreatic neoplasm.